But until insurance companies begin to cover them, or hospitals are willing to try via some sort of pilot project to see if we can do cost containment for them, I think were going to sort of be stuck where we are, which is compounded therapies are right for patients who can afford them, but they are not as widely used as they might be. While direct copies of GLP-1 drugs can no longer be compounded on account of the FDA declaring an end to the shortage, compounding pharmacies can still produce and dispense custom formulations of the drug if prescribed by a doctor
Dispose of contents/container to an approved waste disposal plant
Every comparison, including this one, is cross-trial inference across separate molecules, endpoints, and settings
Blue nevi, Mongolian spots, and nevi of Ota are all types of dermal melanocytosis, representing variants of the same physiological process
19 This effect likely contributes to the decreased risk of stroke in T2D patients receiving treatment with certain GLP-1RAs
In the absence of formal guidance, pharmacists and prescribers must rely on pharmacologic reasoning, cautious titration and vigilant monitoring